Northern Trust
VVOS icon

Northern Trust’s Vivos Therapeutics VVOS Stock Holding History

Northern Trust’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.8K Hold
12,511
– – ﹤0.01% 4353
2025
Q4 		$25.4K Hold
12,511
– – ﹤0.01% 4370
2025
Q3 		$38.8K Hold
12,511
– – ﹤0.01% 4315
2025
Q2 		$39.5K Hold
12,511
– – ﹤0.01% 4271
2025
Q1 		$35.7K Buy
+12,511
New +$49.1K ﹤0.01% 4281
2023
Q4 		– Sell
-1,186
Closed -$5.7K – 4552
2023
Q3 		$5.7K Hold
1,186
– – ﹤0.01% 4428
2023
Q2 		$15.1K Hold
1,186
– – ﹤0.01% 4444
2023
Q1 		$10.1K Hold
1,186
– – ﹤0.01% 4524
2022
Q4 		$11.9K Hold
1,186
– – ﹤0.01% 4558
2022
Q3 		$19K Sell
1,186
-445
-27% -$13.6K ﹤0.01% 4556
2022
Q2 		$52K Hold
1,631
– – ﹤0.01% 4405
2022
Q1 		$109K Buy
1,631
+7
+0.4% +$458 ﹤0.01% 4319
2021
Q4 		$91K Sell
1,624
-17
-1% -$1.37K ﹤0.01% 4451
2021
Q3 		$166K Buy
1,641
+1,182
+258% +$124K ﹤0.01% 4254
2021
Q2 		$57K Buy
+459
New +$74.8K ﹤0.01% 4472

Other funds holding VVOS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Northern Trust's VVOS Position: Q1 2026 in Review

Northern Trust held its Vivos Therapeutics (VVOS) position steady in Q1 2026 at 12,511 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4353.

Northern Trust first reported a position in VVOS in Q2 2021 and has held it in 15 quarters since. The position peaked at $166K in Q3 2021. 24 funds tracked by Wall St. Rank hold VVOS as of Q1 2026.

  • Northern Trust held 12,511 shares of Vivos Therapeutics worth $14.8K as of Q1 2026.
  • Northern Trust left its Vivos Therapeutics share count unchanged in Q1 2026.
  • Vivos Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4353 holding.
  • Northern Trust first reported a position in Vivos Therapeutics in Q2 2021 and has held it in 15 quarters since.
  • Northern Trust's Vivos Therapeutics position peaked at $166K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.